Aurinia Pharmaceuticals Inc
NASDAQ:AUPH

Watchlist Manager
Aurinia Pharmaceuticals Inc Logo
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Watchlist
Price: 8.14 USD -1.45%
Market Cap: 1.2B USD
Have any thoughts about
Aurinia Pharmaceuticals Inc?
Write Note

Aurinia Pharmaceuticals Inc
Current Portion of Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Aurinia Pharmaceuticals Inc
Current Portion of Long-Term Debt Peer Comparison

Comparables:
B
DRUG
TH
RPTX
COV
EDT

Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Current Portion of Long-Term Debt
$14.9m
CAGR 3-Years
N/A
CAGR 5-Years
172%
CAGR 10-Years
N/A
B
Bright Minds Biosciences Inc
CNSX:DRUG
Current Portion of Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Current Portion of Long-Term Debt
$21.4m
CAGR 3-Years
58%
CAGR 5-Years
44%
CAGR 10-Years
23%
Repare Therapeutics Inc
NASDAQ:RPTX
Current Portion of Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Covalon Technologies Ltd
XTSX:COV
Current Portion of Long-Term Debt
CA$666.7k
CAGR 3-Years
8%
CAGR 5-Years
-40%
CAGR 10-Years
N/A
Spectral Medical Inc
TSX:EDT
Current Portion of Long-Term Debt
CA$13m
CAGR 3-Years
425%
CAGR 5-Years
177%
CAGR 10-Years
N/A

See Also

What is Aurinia Pharmaceuticals Inc's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
14.9m USD

Based on the financial report for Sep 30, 2024, Aurinia Pharmaceuticals Inc's Current Portion of Long-Term Debt amounts to 14.9m USD.

What is Aurinia Pharmaceuticals Inc's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 5Y
172%

Over the last year, the Current Portion of Long-Term Debt growth was 12%.

Back to Top